At @ months , the sustained remission rate was nonsignificantly higher in group A ( n = @ ) than group B ( n = @ ; @ % versus @ % ; hazard ratio , @ ; @ % confidence interval , @ to @ ; P = @ ) , and the progression-free survival rate was significantly higher ( @ % versus @ % ; hazard ratio , @ ; @ % confidence interval , @ to @ ; P = @ ) .